Literature DB >> 30570310

A multimethod screening approach for pediatric depression onset: An incremental validity study.

Joseph R Cohen1, Hena Thakur1, Katie L Burkhouse2, Brandon E Gibb1.   

Abstract

OBJECTIVE: Screening protocols that rely on a single informant are inadequate in predicting pediatric depression. Multi-informant and risk factor screening approaches are potentially more sensitive methods for identifying depression risk, but the incremental validity of these protocols has not been adequately tested. Using a translational analytic approach and multimethod, longitudinal study design, we simultaneously tested several multi-indicator approaches to depression screening to identify an optimal algorithm for predicting depression onset in youth.
METHOD: Participants were 222 never-depressed children and adolescents (Mage = 10.75 years old, SDage = 1.85; female = 50.45%; 82.88% White), who completed baseline questionnaires for depressive symptoms and cognitive vulnerabilities, in addition to a morphed face task to assess pupil dilation. Mothers, meanwhile, completed baseline questionnaires and a semistructured interview to assess maternal and pediatric depression. Follow-up depression diagnostic assessments with both the mother and youth occurred every 6 months for 2 years. Receiver operating characteristics and reclassification analyses were used to test our aims.
RESULTS: Overall, we found moderate support for a multi-informant approach, and convincing evidence that individual differences in pupil dilation uniquely predicted depression onset. Youth with subthreshold depressive symptoms and elevated pupil dilation were over twice as likely to develop a first lifetime episode of depression compared to one's risk rate based on sex and age.
CONCLUSIONS: Our study provides one of the first screening batteries for detecting first lifetime episodes of depression in youth. The unique and incremental validity provided by pupil dilation suggests feasible biological indicators of depression risk can improve primary prevention efforts that target depression, such as universal pediatric depression screening. (PsycINFO Database Record (c) 2019 APA, all rights reserved).

Entities:  

Mesh:

Year:  2018        PMID: 30570310      PMCID: PMC6336512          DOI: 10.1037/ccp0000364

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  87 in total

Review 1.  Incremental validity and the assessment of psychopathology in adults.

Authors:  Howard N Garb
Journal:  Psychol Assess       Date:  2003-12

2.  Research domain criteria (RDoC): toward a new classification framework for research on mental disorders.

Authors:  Thomas Insel; Bruce Cuthbert; Marjorie Garvey; Robert Heinssen; Daniel S Pine; Kevin Quinn; Charles Sanislow; Philip Wang
Journal:  Am J Psychiatry       Date:  2010-07       Impact factor: 18.112

3.  Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data.

Authors:  J Kaufman; B Birmaher; D Brent; U Rao; C Flynn; P Moreci; D Williamson; N Ryan
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1997-07       Impact factor: 8.829

4.  The pupil as a measure of emotional arousal and autonomic activation.

Authors:  Margaret M Bradley; Laura Miccoli; Miguel A Escrig; Peter J Lang
Journal:  Psychophysiology       Date:  2008-02-11       Impact factor: 4.016

5.  Evidence-Based Assessment from Simple Clinical Judgments to Statistical Learning: Evaluating a Range of Options Using Pediatric Bipolar Disorder as a Diagnostic Challenge.

Authors:  Eric A Youngstrom; Tate F Halverson; Jennifer K Youngstrom; Oliver Lindhiem; Robert L Findling
Journal:  Clin Psychol Sci       Date:  2017-12-08

6.  The hopelessness theory of depression: a test of the diathesis-stress and causal mediation components in third and seventh grade children.

Authors:  J R Abela
Journal:  J Abnorm Child Psychol       Date:  2001-06

7.  Inter-rater reliability of the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID I) and Axis II Disorders (SCID II).

Authors:  Jill Lobbestael; Maartje Leurgans; Arnoud Arntz
Journal:  Clin Psychol Psychother       Date:  2011 Jan-Feb

8.  A primer on receiver operating characteristic analysis and diagnostic efficiency statistics for pediatric psychology: we are ready to ROC.

Authors:  Eric A Youngstrom
Journal:  J Pediatr Psychol       Date:  2013-08-21

9.  How does dysfunctional thinking decrease during recovery from major depression?

Authors:  Leyland C Sheppard; John D Teasdale
Journal:  J Abnorm Psychol       Date:  2004-02

10.  A longitudinal study of depression in an urban Spanish pubertal population.

Authors:  J Canals; C Marti-Henneberg; J Fernández-Ballart; E Domènech
Journal:  Eur Child Adolesc Psychiatry       Date:  1995-04       Impact factor: 4.785

View more
  5 in total

1.  Youth Depression Screening with Parent and Self-Reports: Assessing Current and Prospective Depression Risk.

Authors:  Joseph R Cohen; Felix K So; Jami F Young; Benjamin L Hankin; Brenda A Lee
Journal:  Child Psychiatry Hum Dev       Date:  2019-08

2.  Is ACEs Screening for Adolescent Mental Health Accurate and Fair?

Authors:  Joseph R Cohen; Jae Wan Choi
Journal:  Prev Sci       Date:  2022-07-01

Review 3.  Eye pupil - a window into central autonomic regulation via emotional/cognitive processing.

Authors:  N Ferencová; Z Višňovcová; L Bona Olexová; I Tonhajzerová
Journal:  Physiol Res       Date:  2021-12-30       Impact factor: 2.139

4.  Multiple domains of risk factors for first onset of depression in adolescent girls.

Authors:  Giorgia Michelini; Greg Perlman; Yuan Tian; Daniel M Mackin; Brady D Nelson; Daniel N Klein; Roman Kotov
Journal:  J Affect Disord       Date:  2021-01-14       Impact factor: 4.839

5.  [The national treatment guidelines on depression need more courageous and more differentiated statements on psychotherapy].

Authors:  Winfried Rief; Eva-Lotta Brakemeier; Tim Kaiser; Tilo Kircher; Klaus Lieb; Jürgen Margraf; Johannes Michalak; Andreas Reif; Silvia Schneider; Ulrich Voderholzer
Journal:  Nervenarzt       Date:  2022-07-14       Impact factor: 1.297

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.